BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1177050)

  • 1. Bone marrow imaging using 111In-citrate: 111In-kinetics in the pelvic region.
    Glaubitt DM; Schlüter IH; Haberland KU
    J Nucl Med; 1975 Aug; 16(8):769-74. PubMed ID: 1177050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the distribution of hematopoietic bone marrow by bone marrow scintigraphy. III. The bone marrow scintigraphy with 111In-chloride (author's transl)].
    Fujimori K
    Nihon Ketsueki Gakkai Zasshi; 1976 Apr; 39(2):131-7. PubMed ID: 1036859
    [No Abstract]   [Full Text] [Related]  

  • 3. [99mTc-sulfur-rhenium colloid and 111In-indium citrate in bone-marrow scintigraphy].
    Glaubitt D; Haberland K; Knoch K; Fejér FL; Zachariah S
    Blut; 1975 Mar; 30(3):213-21. PubMed ID: 1122342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone-marrow imaging in pure red blood cell aplasia.
    Bunn HF; McNeil BJ; Rosenthal DS; Krantz SB
    Arch Intern Med; 1976 Oct; 136(10):1169-72. PubMed ID: 971017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. As bone marrow scintigraphy in patients treated with chemotherapy and/or radiotherapy.
    Brousil J; Foltýnová V; Vĕtrovcová E; Tichá E
    Nuklearmedizin; 1977 Apr; 16(2):86-8. PubMed ID: 876848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow scintigraphy in anemia caused by impaired hemopoiesis. Respective values of technetium colloids and indium-transferrin].
    Rain JD; Castro-Malaspina H; Dresch C; Najean Y
    Nouv Presse Med; 1975 May; 4(20):1471-6. PubMed ID: 1215143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of carcinoma of the cervix using 111In-bleomycin.
    Woolfenden JM; Waxman AD; Disaia PJ; Siemsen JK
    Obstet Gynecol; 1975 Sep; 46(3):347-52. PubMed ID: 51490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [RI cisternography with 111-In-DTPA].
    Tokuriki Y; Miwa Y; Murata T; Fukumitsu T; Matsumura T
    No To Shinkei; 1976 Jun; 28(6):579-88. PubMed ID: 1036152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
    Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
    J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of 111In with 52Fe and 99mTc-sulfur colloid for bone marrow scanning.
    Merrick MV; Gordon-Smith EC; Lavender JP; Szur L
    J Nucl Med; 1975 Jan; 16(1):66-8. PubMed ID: 1089139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic substantiation of the use of 111In-citrate in bone marrow studies].
    Korsunskiĭ VN; Tarasenko IuI; Koval'chuk ND; Kosheleva IIu; Popov VI
    Med Radiol (Mosk); 1986 Jul; 31(7):48-52. PubMed ID: 3736386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of autologous indium (111In)-labelled platelets in the diagnosis of renal transplant rejection.
    Fenech A; Smith FW; Power DA; MacLeod AM; Nicholls AJ; Edward N; Catto GR; Bennett B
    Clin Nephrol; 1984 Apr; 21(4):220-2. PubMed ID: 6375924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.
    Carrasquillo JA; White JD; Paik CH; Raubitschek A; Le N; Rotman M; Brechbiel MW; Gansow OA; Top LE; Perentesis P; Reynolds JC; Nelson DL; Waldmann TA
    J Nucl Med; 1999 Feb; 40(2):268-76. PubMed ID: 10025834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of contaminant indium-114m/indium-114 to indium-111 oxine blood dosimetry.
    Marcus CS; Stabin MG; Watson EE; Kuperus JH
    J Nucl Med; 1985 Sep; 26(9):1091-3. PubMed ID: 3928839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative bone and bone marrow sampling: a simple method for accurate measurement of uptake of radiopharmaceuticals in bone and bone marrow.
    Oyen WJ; Buijs WC; van Kampen A; Koenders EB; Claessens RA; Corstens FH
    Nucl Med Commun; 1993 Feb; 14(2):112-6. PubMed ID: 8429988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
    Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
    J Nucl Med; 1998 Mar; 39(3):476-84. PubMed ID: 9529295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Scintigraphy of the bone marrow (author's transl)].
    Rain JD; Eberlin A; Boulard M; Dresch C; Najean Y
    Nouv Rev Fr Hematol; 1973; 13(6):789-801. PubMed ID: 4280044
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
    Shen S; Meredith RF; Duan J; Macey DJ; Khazaeli MB; Robert F; LoBuglio AF
    J Nucl Med; 2002 Sep; 43(9):1245-53. PubMed ID: 12215566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Splenic uptake of 111In.
    Vieras F
    J Nucl Med; 1975 Dec; 16(12):1205-6. PubMed ID: 1194979
    [No Abstract]   [Full Text] [Related]  

  • 20. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
    Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W
    J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.